Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-617-08
Published August 30, 2023 · Recall initiated: July 21, 2023
Summary
FDA records drug Class II recall D-1088-2023, published August 30, 2023 and initiated July 21, 2023. Recalling firm: Aurobindo Pharma USA Inc.; Status: Terminated; Reported quantity: 48 bottles; Lot: Lot #: RB4023002A, Exp 02/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP deviations: Batch was released prior to approval.
What to do
Voluntary: Firm initiated · Letter
Get an email if RUFINAMIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- RUFINAMIDE
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- USA nationwide
- UPC
- 0359651616086
- Lot
- Lot #: RB4023002A, Exp 02/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARufinamide Tablets 200mg, 120-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,April 16, 2025
- FDARufinamide Tablets, USP 200 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA,August 30, 2023
- FDAProtex Foaming Hand Sanitizer (Benzalkonium Chloride 0.13%), packaged in a) 2 fl oz/60 mL Pump bottles (NDCAugust 30, 2023
- FDAHelix Pain Relieving Cream (Menthol 7.4%), packaged in a) 5 gm pouch (NDC 30775-051-01), b) 3 fl. oz. roll-onAugust 30, 2023
- FDASnowden-Pencer MIS DIAMOND-TOUCH CLAMP DEBAKEY 35 MM JAW 5MM, 32CM, RATCHETED, REF SP90-7044; endoscopicAugust 23, 2023
- FDAMedtronic REF 46915 Duet External Drainage and Monitoring system, Interlink Injection sites, VentricularAugust 23, 2023
Questions about this recall
Was Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-617-08 recalled?
Yes. FDA published recall D-1088-2023 on August 30, 2023. Reported hazard: cGMP deviations: Batch was released prior to approval.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: RUFINAMIDE. UPC: 0359651616086.